$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can Leborex completely cure insomnia?
2025-10-19 11:44:20
Check Details
Can I drink alcohol while taking Lebrasin?
2025-10-19 11:44:20
Check Details
Is Lebraxen a psychotropic drug?
2025-10-19 11:44:20
Check Details
Is there resistance to the sleeping pill Leborex?
2025-10-19 11:44:20
Check Details
What drug should I switch to after becoming resistant to leborexan?
2025-10-19 11:44:20
Check Details
What is the therapeutic effect of Lebolaysen
2025-10-19 11:44:20
Check Details
What are the adverse reactions of Lebraxen?
2025-10-19 11:44:20
Check Details
How effective is the new drug Lemborexant for treating insomnia?
2025-10-19 11:44:20
Check Details
The difference between Leboreson and Suvoreson
2025-10-19 11:44:20
Check Details
Indications, usage, dosage and drug interactions of Lebraxen?
2025-10-19 11:44:20
Check Details
Why can't lemborexant completely cure insomnia?
2025-10-19 11:44:20
Check Details
What is the mechanism of action and clinical improvement effect of lemborexant?
2025-10-19 11:44:20
Check Details
1
2
...
2801
2802
2803
2804
2805
2806
2807
...
10217
10218
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
2
Omaveloxolone (Skyclarys): Side Effect Management and Clinical Guide for Friedreich’s Ataxia
3
Linezolid for MRSA Pneumonia: Efficacy Evidence, Clinical Advantages, and Rational Use
4
Navigating Drug Interactions with Daprodustat: Risks, Adjustments, and Safety Protocols
5
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
6
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
7
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
8
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
9
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
10
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
11
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth
12
Tofacitinib: The Role and Considerations of an Oral JAK Inhibitor in Autoimmune Disease Treatment